A novel series of IKKβ inhibitors part II: description of a potent and pharmacologically active series of analogs.
暂无分享,去创建一个
N. Walker | R. C. Hawley | C. Broka | A. Gill | V. Baichwal | M. Browner | S. Miao | J. Jaén | G. Tonn | Karen Berry | S. Dalrymple | J. Mcintosh | Michael R Degraffenreid | X. He | M. Labelle | F. Talamas | S. Labadie | M. Wright | H. Wesche | C. Parast | P. Lu | Xiaolin Hao | Y. Shin | C. Lehel | R. Billedeau | M. Cardozo | P. Cheng | Marie L. Smith | T. Cushing | V. Bordunov | David Clark | E. Sjogren | K.A.M. Walker | C. Whitehead
[1] N. Walker,et al. A novel series of IKKβ inhibitors part I: Initial SAR studies of a HTS hit. , 2011, Bioorganic & medicinal chemistry letters.
[2] M. May,et al. The IκB kinase complex: master regulator of NF-κB signaling , 2008, Immunologic research.
[3] M. Karin,et al. The two NF-κB activation pathways and their role in innate and adaptive immunity , 2004 .
[4] Mike Rothe,et al. IκB Kinase-β: NF-κB Activation and Complex Formation with IκB Kinase-α and NIK , 1997 .
[5] D. Goeddel,et al. Identification and Characterization of an IκB Kinase , 1997, Cell.